Abstract
Chronic use of marijuana impairs synaptic plasticity and cognitive function. However, the molecular mechanisms by which marijuana alters long-term synaptic plasticity are largely unknown. Here, we show that repeated in vivo exposures to Delta9-THC for 7 consecutive days significantly impaired hippocampal long-term potentiation (LTP) of excitatory glutamatergic synaptic transmission. The Delta9-THC exposure-induced decrease in LTP was prevented by pharmacological inhibition or deletion of the cannabinoid 1 receptor (CB1R). To determine the molecular mechanisms underlying Delta9-THC-altered LTP, we targeted expression and function of the glutamate receptors (GluR) and phosphorylation status of cAMP-response element-binding protein (CREB). Chronic in vivo exposure to Delta9-THC produced CB1R-dependent decreases in expression of hippocampal GluR1, NR2A, and NR2B, the ratio of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)/NMDA receptor-gated currents, and phosphorylation of CREB. Our results suggest that reduced expression and function of the GluR subunits and phosphorylation of CREB may underlie the impaired long-term synaptic plasticity induced by repeated in vivo exposure to Delta9-THC.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
2-Amino-5-phosphonovalerate / pharmacology
-
Animals
-
Bicuculline / pharmacology
-
Biophysics
-
Biotinylation
-
CREB-Binding Protein / metabolism*
-
Dronabinol / pharmacology*
-
Electric Stimulation / methods
-
Excitatory Amino Acid Antagonists / pharmacology
-
Excitatory Postsynaptic Potentials / drug effects
-
Excitatory Postsynaptic Potentials / genetics
-
GABA Antagonists / pharmacology
-
Gene Expression Regulation / drug effects
-
Gene Expression Regulation / physiology*
-
Hippocampus / cytology*
-
Hippocampus / drug effects
-
In Vitro Techniques
-
Long-Term Potentiation / drug effects*
-
Long-Term Potentiation / genetics
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Patch-Clamp Techniques / methods
-
Phosphorylation / drug effects
-
Psychotropic Drugs / pharmacology
-
Receptor, Cannabinoid, CB1 / deficiency
-
Receptors, AMPA / genetics
-
Receptors, AMPA / metabolism
-
Receptors, Glutamate / genetics
-
Receptors, Glutamate / metabolism*
-
Receptors, N-Methyl-D-Aspartate / genetics
-
Receptors, N-Methyl-D-Aspartate / metabolism
-
Synapses / drug effects*
Substances
-
Excitatory Amino Acid Antagonists
-
GABA Antagonists
-
NR2A NMDA receptor
-
NR2B NMDA receptor
-
Psychotropic Drugs
-
Receptor, Cannabinoid, CB1
-
Receptors, AMPA
-
Receptors, Glutamate
-
Receptors, N-Methyl-D-Aspartate
-
2-Amino-5-phosphonovalerate
-
Dronabinol
-
CREB-Binding Protein
-
glutamate receptor ionotropic, AMPA 1
-
Bicuculline